Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR) (the "Company") announced the following today:
The Company anticipates that it will not be able to consummate an initial business combination within the